June 14, 2024

1078-P: The Impact of Telemedicine Use on Subsequent Glycemic Control in Patients with Diabetes

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Introduction Eli Lilly and Company, Novo Nordisk. Consultant; Novo Nordisk, Proteomics International. Research Support; AstraZeneca. Funding National Institutes of Health (T32DK007529)

Me gusta

Guardar

Cite This Study

Thurber et al. (Fri,) studied this question.

synapsesocial.com/papers/68e64c55b6db6435875dd6fe https://doi.org/https://doi.org/10.2337/db24-1078-p

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

112603 The Effect Of Telemedicine On Glycemic Control In Patients With Type 2 Diabetes2024
2Telemedicine’s Impact on Diabetes Care during the COVID-19 Pandemic: A Cohort Study in a Large Integrated Healthcare System2024 · 4 citations
3Impact of COVID-19 on A1c Management and Telehealth Use Among a Type 2 Diabetes Mellitus Population in the Outpatient Setting2025
4Evaluation of the clinical outcomes of telehealth for managing diabetes2018 · 92 citations
5Telemedicine versus In-Person Pediatric Outpatient Type 1 Diabetes Visits Impact on Immediate Glycemic Control: Retrospective Chart Review (Preprint)2024

Me gusta

Guardar